| 耐碳青霉烯类肺炎克雷伯菌医院感染、耐药性及治疗的研究进展 |
| |
| 摘 要： | 医院感染的主要病原菌是肠杆菌科细菌。由于临床上对于抗菌药物的不合理使用，使得耐碳青霉烯类肠杆菌科细菌(carbapenem-resistant Enterobacteriaceae，CRE)的检出率不断增加，而耐碳青霉烯类肺炎克雷伯菌(carbapenem-resistant Klebsiella
|
| 关 键 词： | 碳青霉烯类 肺炎克雷伯菌 医院感染 耐药机制 治疗 /> |
Advances in research on nosocomial infection,drug resistance and treatment of carbapenem-resistant Klebsiella pneumoniae |
| |
| Abstract: | At present, the main pathogen of nosocomial infections is Enterobacteriaceae. Due to the irrational use of antibacterial drugs in the clinic, the detection rate of carbapenem-resistant Enterobacteriaceae (CRE) is increasing, while carbapenem-resistant Klebsiella pneumoniae (CRKP) is the most common CRE in clinical isolates.This article will introduce the status quo of CRKP infections, influencing factors, drug resistance mechanisms, to improve people’s attention and control of CRKP infection, in order to provide effective antibacterial drugs and clinical combination treatment of |
| |
| Keywords: | Carbapenem Klebsiella pneumoniae Hospital infection Resistance mechanism Treatment |
|
| 点击此处可从《中国抗生素杂志》浏览原始摘要信息 |
| 点击此处可从《中国抗生素杂志》下载免费的PDF全文 |
